Connect
MJA
MJA

Oestrogen — a new treatment approach for schizophrenia?

Jayashri Kulkarni
Med J Aust 2009; 190 (4): 37.
  • Jayashri Kulkarni

  • Alfred Psychiatry Research Centre, Monash University and Alfred Hospital, Melbourne, VIC.

Correspondence: J.Kulkarni@alfred.org.au

Competing interests:

None identified.

  • 1. Häfner H. The epidemiology of beginning schizophrenia. In: WPA section of Epidemiology and Community Psychiatry Symposium; 1991 Jun 14–16; Oslo.
  • 2. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16: 185-195.
  • 3. Kraepelin E. Dementia praecox and paraphrenia (translated by Barclay RM, Robertson GM). Extracted from: Psychiatrie. Vol 3. 8th ed (1910). Edinburgh: Livingstone, 1919.
  • 4. Angermeyer MC, Kühn L. Gender differences in age at onset of schizophrenia. Eur Arch Psychiatry Neurol Sci 1988; 237: 351-364.
  • 5. Häfner H. Gender differences in schizophrenia. In: Bergemann N, Riecher-Rössler A, editors. Estrogen effects in psychiatric disorders. Vienna: Springer-Verlag, 2005: 53-94.
  • 6. Loffler W, Häfner H, Fatkenheuer B, et al. Validation of Danish case register for schizophrenia. Acta Psychiatr Scand 1994; 90: 196-203.
  • 7. Riecher-Rössler A, Häfner H, Stumbaum M, et al. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994; 20: 203-214.
  • 8. Riecher-Rössler A. Estrogens and schizophrenia. In: Bergemann N, Riecher-Rössler A, editors. Estrogen effects in psychiatric disorders. Vienna: Springer-Verlag, 2005: 31-52.
  • 9. Fink G. The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. In: Takada A, Curzon G, editors. Serotonin in the central nervous system and periphery. Amsterdam: Elsevier Science BV, 1995: 175-187.
  • 10. Mosselman S, Polman J, Dukema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392: 49-53.
  • 11. Kulkarni J, de Castella A, Smith D, et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizoph Res 1996; 20: 247-252.
  • 12. Kulkarni J, de Castella A, Riedel A, et al. Estrogen — a potential new treatment in schizophrenia. Schizophr Res 2001; 48: 137-144.
  • 13. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
  • 14. Kulkarni J, de Castella A, Fitzgerald P, et al. Estrogen in severe mental illness. A potential new treatment approach. Arch Gen Psychiatry 2008; 65: 955-960.
  • 15. Kulkarni J. Clinical estrogen trials in patients with schizophrenia. In: Bergemann N, Riecher-Rössler A, editors. Estrogen effects in psychiatric disorders. Vienna: Springer-Verlag, 2005: 107-123.
  • 16. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
  • 17. Chlebowski RT, Hendrix SL, Langer RD, et al; WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA 2003; 289: 3243-3253.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.